Atorvastatin Reduces the Risk of Cardiovascular Events in Patients With Carotid Atherosclerosis: A Secondary Analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Trial
暂无分享,去创建一个
M. Hennerici | L. Goldstein | H. Sillesen | K. Welch | J. Zivin | A. Callahan | Michael Messig | Pierre Amarenco